N/A
N=808
A Russian Prospective Observational Study of Invasive Fungal Infections in Patients With Acute Leukemia and Hematopoietic Stem Cell Transplantation
Invasive Fungal Infections
Bottom Line
View on ClinicalTrials.gov: NCT01519648 ↗Enrolled (actual)
808
Serious AEs
—
Results posted
Jul 2014
Primary outcome: Primary: The Rate of Invasive Fungal Infections — 77; 27 participants — p=0.007
Study Design & Population
- Study type
- Observational
- Phase
- N/A
- Interventions
- —
- Age
- Pediatric, Adult, Older Adult · 1+ yrs
- Sex
- All
- Sponsor
- National Hematological Society, Russia
- Primary completion
- Sep 2013
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY The Rate of Invasive Fungal Infections |
77; 27 | 0.007 sig |
Summary
Estimate the rate of occurrence of Invasive Fungal Infections (IFIs) in patients with acute leukemia for the first 6 months of chemotherapy (that usually correspond to four courses of chemotherapy), and hematopoietic stem cells transplantation.
Eligibility Criteria
Inclusion Criteria
- Diagnosed with de novo or relapsed AL (AML, ALL)started chemotherapy
- All newly allogeneic or autologous transplant recipients during the study period
Data sourced from ClinicalTrials.gov (NCT01519648). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.